Repository logo
 
Publication

Dual-crosslinked injectable in situ forming Alginate/CaCl2/Pluronic F127/ α-Cyclodextrin hydrogels incorporating Doxorubicin and graphene-based nanomaterials for cancer chemo-photothermal therapy

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorGonçalves, Joaquim
dc.contributor.authorMelo, Bruna Daniela Lopes
dc.contributor.authorPouso, Manuel António do Rosário
dc.contributor.authorCorreia, Ilídio Joaquim Sobreira
dc.contributor.authorde Melo-Diogo, Duarte
dc.date.accessioned2025-10-02T14:02:42Z
dc.date.available2025-10-02T14:02:42Z
dc.date.issued2025-09-11
dc.description.abstractInjectable in situ forming hydrogels have been emerging due to their capacity to perform the direct delivery of therapeutics into the tumor site with minimal off-target leakage. Particularly, physical crosslinked injectable in situ forming hydrogels are appealing due to their straightforward preparation that exploits the native jointing capabilities of specific polymers/materials. However, the features of these hydrogels (e.g., injectability, degradation, swelling) are strongly pre-determined by the physical interactions available on the selected polymers/ materials, occasionally yielding undesired outcomes. Thus, the combination of multiple physical crosslinking cues may allow the preparation of hydrogels with enhanced properties. In this work, a dual-crosslinked injectable in situ forming hydrogel was engineered by combining Pluronic F127/α-Cyclodextrin and Alginate/CaCl2 (i.e., combination of host-guest and electrostatic interactions), being loaded with Doxorubicin (chemotherapeutic drug) and Dopamine-reduced Graphene Oxide (photothermal nano-agent) for application in cancer chemophotothermal therapy. When compared to the single-crosslinked hydrogels, the dual-crosslinking contributed to the assembly of formulations with suitable injectability and improved degradation and water absorption behaviors. Moreover, the dual-crosslinked hydrogels presented a good photothermal capacity (ΔT ≈ 14 ◦C), leading to a 1.18-times enhanced Doxorubicin release. In in vitro cell-based studies, the dual-crosslinked hydrogels exhibited an excellent cytocompatibility towards healthy (normal human dermal fibroblasts) and breast cancer (MCF-7) cells. As importantly, the dual-crosslinked hydrogels were able to mediate a chemophotothermal effect that diminished the cancer cells’ viability to just 23 %. Overall, the developed dualcrosslinked injectable in situ forming hydrogels incorporating Doxorubicin and Dopamine-reduced Graphene Oxide are a promising macroscale system for breast cancer chemo-photothermal therapy.por
dc.description.sponsorshipThis research was funded in whole or in part by the Fundaç˜ao para a Ciˆencia e a Tecnologia, I.P. (FCT, https://ror.org/00snfqn58) under the Grants 10.54499/UIDB/00709/2020 (https://doi.org/10.544 99/UIDB/00709/2020), 10.54499/UIDP/00709/2020 (https://doi. org/10.54499/UIDP/00709/2020), PTDC/BTABTA/0696/2020, 2022.06320.PTDC (DOI 10.54499/2022.06320.PTDC), 10.54499/LA/ P/0079/2020 and 10.54499/UIDB/50022/2020. The project COMPETE2030-FEDER-00695800 is also acknowledged.
dc.identifier.citationGonçalves, J. J., Melo, B. L., Pouso, M. R., Correia, I. J., & de Melo-Diogo, D. (2025). Dual-crosslinked injectable in situ forming Alginate/CaCl2/Pluronic F127/α-Cyclodextrin hydrogels incorporating Doxorubicin and Graphene-based nanomaterials for cancer chemo-photothermal therapy. Journal of Drug Delivery Science and Technology, 107520
dc.identifier.doihttps://doi.org/10.1016/j.jddst.2025.107520
dc.identifier.issn1773-2247
dc.identifier.urihttp://hdl.handle.net/10400.6/18944
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier
dc.relationShear-thinning and self-healing hydrogels: tuning the polymer-related features for the tumor confined delivery of therapeutics aimed for metastatic breast cancer immuno-photothermal therapy
dc.relationThiol-ene click injectable in situ forming hydrogels incorporating graphene: optimization of the polymer-related features for the immuno-photothermal therapy of metastatic breast cancer
dc.relationBolsa de Doutoramento - Biotecnologia Médica
dc.relation.hasversionhttps://www.sciencedirect.com/science/article/pii/S1773224725009232?via%3Dihub
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCancer
dc.subjectChemo-photothermal therapy
dc.subjectGraphene family nanomaterials
dc.subjectInjectable hydrogels
dc.subjectLocal delivery
dc.subjectMacroscale delivery systems
dc.titleDual-crosslinked injectable in situ forming Alginate/CaCl2/Pluronic F127/ α-Cyclodextrin hydrogels incorporating Doxorubicin and graphene-based nanomaterials for cancer chemo-photothermal therapypor
dc.typeresearch article
dspace.entity.typePublication
oaire.awardTitleShear-thinning and self-healing hydrogels: tuning the polymer-related features for the tumor confined delivery of therapeutics aimed for metastatic breast cancer immuno-photothermal therapy
oaire.awardTitleThiol-ene click injectable in situ forming hydrogels incorporating graphene: optimization of the polymer-related features for the immuno-photothermal therapy of metastatic breast cancer
oaire.awardTitleBolsa de Doutoramento - Biotecnologia Médica
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/CEEC IND4ed/2021.00590.CEECIND%2FCP1661%2FCT0001/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/Concurso de Projetos de I&D em Todos os Domínios Científicos - 2022/2022.06320.PTDC/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/POR_CENTRO/2021.06044.BD/PT
oaire.citation.startPage107520
oaire.citation.titleJournal of Drug Delivery Science and Technology
oaire.citation.volume114
oaire.fundingStreamCEEC IND4ed
oaire.fundingStreamConcurso de Projetos de I&D em Todos os Domínios Científicos - 2022
oaire.fundingStreamPOR_CENTRO
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameGonçalves
person.familyNameMelo
person.familyNamePouso
person.familyNameCorreia
person.familyNamede Melo-Diogo
person.givenNameJoaquim
person.givenNameBruna Daniela Lopes
person.givenNameManuel António do Rosário
person.givenNameIlídio Joaquim Sobreira
person.givenNameDuarte
person.identifierUMbJ1KMAAAAJ
person.identifierC2z5x04AAAAJ
person.identifier.ciencia-idA613-7659-3BA9
person.identifier.ciencia-id5717-CB52-B4E5
person.identifier.ciencia-idEB15-3F85-263D
person.identifier.ciencia-idF610-7373-DC81
person.identifier.ciencia-id9C10-9BD8-634E
person.identifier.orcid0009-0008-2314-701X
person.identifier.orcid0000-0002-0078-1877
person.identifier.orcid0000-0001-9816-6284
person.identifier.orcid0000-0003-1613-9675
person.identifier.orcid0000-0001-9984-3603
person.identifier.scopus-author-id7003557499
person.identifier.scopus-author-id56266511300
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
relation.isAuthorOfPublication6681349e-e581-4a26-9d83-02ca4cbae502
relation.isAuthorOfPublicationd375e555-1edb-4f4e-b888-9973932767ff
relation.isAuthorOfPublicationf4166921-0e42-421a-960c-b38e969fc0b0
relation.isAuthorOfPublicationf2c3e779-34a2-4309-950a-80687664c6ad
relation.isAuthorOfPublication8525f1be-ff8f-4e46-b158-e59928e8a3e5
relation.isAuthorOfPublication.latestForDiscovery6681349e-e581-4a26-9d83-02ca4cbae502
relation.isProjectOfPublicationa17b9378-dba9-4d78-b3db-f77e06c60446
relation.isProjectOfPublication2de44aa4-bd29-42fc-bcab-b9b6e69d0c00
relation.isProjectOfPublication3366c12b-f1a7-4c52-8858-e1b066dc7289
relation.isProjectOfPublication.latestForDiscoverya17b9378-dba9-4d78-b3db-f77e06c60446

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2025 Gonçalves DDST.pdf
Size:
2.82 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description: